GlaxoSmithKline’s $1.9 Billion Acquisition of Sierra Oncology

Cleary Gottlieb Steen & Hamilton advised GlaxoSmithKline, while Wilson Sonsini Goodrich & Rosati advised Sierra Oncology on the deal.GlaxoSmithKline plc (LSE/NYSE: GSK) has entered into an agreement…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here